tiprankstipranks
Intra-Cellular Therapies (ITCI)
NASDAQ:ITCI
Holding ITCI?
Track your performance easily

Intra-Cellular Therapies (ITCI) Financial Statements

882 Followers

Intra-Cellular Therapies Financial Overview

Intra-Cellular Therapies's market cap is currently ―. The company's EPS TTM is $-0.859; its P/E ratio is -99.70; Intra-Cellular Therapies is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 175.38M$ 161.39M$ 144.84M$ 131.51M$ 126.17M
Gross Profit$ 175.38M$ 161.39M$ 134.94M$ 120.80M$ 126.17M
EBIT$ -25.95M$ -16.16M$ -20.95M-$ -24.21M
EBITDA$ -25.81M$ -13.69M$ -20.82M-$ -24.08M
Net Income Common Stockholders$ -26.32M$ -16.22M$ -15.25M$ -28.58M$ -24.26M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.01B$ 1.02B$ 475.62M$ 497.94M$ 493.02M
Total Assets$ 1.32B$ 1.32B$ 747.04M$ 728.29M$ 717.66M
Total Debt$ 17.71M$ 18.29M$ 16.38M$ 16.94M$ 17.48M
Net Debt$ -988.85M$ -1.00B$ -459.25M$ -481.00M$ -475.55M
Total Liabilities$ 179.62M$ 175.89M$ 147.54M$ 136.87M$ 116.98M
Stockholders Equity$ 1.14B$ 1.14B$ 599.50M$ 591.42M$ 600.68M
Cash Flow-
Free Cash Flow$ -27.22M$ 489.00K$ -34.12M-$ -25.54M
Operating Cash Flow$ -26.52M$ 542.00K$ -34.12M$ -2.06M$ -25.27M
Investing Cash Flow$ -209.20M$ 7.77M$ 16.18M$ 47.42M$ -20.17M
Financing Cash Flow$ 6.73M$ 545.18M$ 9.99M$ 3.00M$ 2.58M
Currency in USD

Intra-Cellular Therapies Earnings and Revenue History

Intra-Cellular Therapies Debt to Assets

Intra-Cellular Therapies Cash Flow

Intra-Cellular Therapies Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis